Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Theravance Biopharma Inc TBPH

Set alert

Price alert · TBPH

All alert types
17.03 USD 0.00 0.00%

At close · Sep 23

17.63 +0.60 +3.52%

After hours · Sep 23, 4:00 PM ET

Bid
17.63 × 2
Ask
17.65 × 2
17.02 Day range 17.07
7.44 52-week range 11.71
YTD
-8.98%
1 year
+58.71%
Open
17.06
Prev close
17.03
Mkt cap
481.42M
Vol
10.02M
Avg vol
194.24K
EPS
-1.03
P/E
10.92
Div yield
0.00%
More statistics
Low
17.02
High
17.07
Forward P/E
163.17
Beta
0.25
Short ratio
19.79
Inst. own
96.71%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2026
50-d avg
9.19
200-d avg
8.90
1y target
13.20

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for TBPH has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.01 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 8.9×
FY 2016: -7.5×FY 2017: -5.1×FY 2018: -6.4×FY 2019: -6.1×FY 2020: -4.0×FY 2021: -3.9×FY 2022: -8.9×FY 2023: -11.2×FY 2024: -8.2×FY 2025: 8.9×
FY 2016 5y median -8.2× FY 2025
P/S 8.8×
FY 2016: 29.3×FY 2017: 94.9×FY 2018: 22.9×FY 2019: 19.6×FY 2020: 15.4×FY 2021: 13.9×FY 2022: 16.1×FY 2023: 10.8×FY 2024: 7.1×FY 2025: 8.8×
FY 2016 5y median 10.8× FY 2025
P/B 3.2×
FY 2016: 4.1×FY 2017: 12.7×FY 2018: -26.8×FY 2019: -6.4×FY 2020: -3.6×FY 2021: -2.3×FY 2022: 1.9×FY 2023: 2.9×FY 2024: 2.6×FY 2025: 3.2×
FY 2016 5y median 2.6× FY 2025
P/FCF 3.9×
FY 2016: -14.1×FY 2017: -7.2×FY 2018: -11.5×FY 2019: -6.0×FY 2020: -4.3×FY 2021: -3.6×FY 2022: -4.4×FY 2023: -21.1×FY 2024: -38.7×FY 2025: 3.9×
FY 2016 5y median -4.4× FY 2025
EV/EBITDA 6.2×
FY 2016: -7.4×FY 2017: -6.2×FY 2018: -6.9×FY 2019: -9.3×FY 2020: -5.9×FY 2021: -5.9×FY 2022: -8.0×FY 2023: -12.8×FY 2024: -12.3×FY 2025: 6.2×
FY 2016 5y median -8.0× FY 2025
EV/Sales 7.9×
FY 2016: 26.8×FY 2017: 104×FY 2018: 24.1×FY 2019: 25.8×FY 2020: 23.7×FY 2021: 24.4×FY 2022: 11.3×FY 2023: 11.0×FY 2024: 7.3×FY 2025: 7.9×
FY 2016 5y median 11.0× FY 2025
FCF Yield 25.3%
FY 2016: -7.1%FY 2017: -13.9%FY 2018: -8.7%FY 2019: -16.8%FY 2020: -23.2%FY 2021: -27.5%FY 2022: -22.7%FY 2023: -4.7%FY 2024: -2.6%FY 2025: 25.3%
FY 2016 5y median -4.7% FY 2025

Profitability

Gross Margin 94.9%
FY 2016: 94.1%FY 2017: 60.8%FY 2018: 98.8%FY 2019: 100.0%FY 2020: 100.0%FY 2021: -250.1%FY 2022: -23.5%FY 2023: 29.3%FY 2024: 41.5%FY 2025: 94.9%
FY 2016 5y median 29.3% FY 2025
Operating Margin -12.3%
FY 2016: -371.0%FY 2017: -1690.6%FY 2018: -395.5%FY 2019: -343.1%FY 2020: -414.2%FY 2021: -466.1%FY 2022: -179.1%FY 2023: -97.6%FY 2024: -72.9%FY 2025: -12.3%
FY 2016 5y median -97.6% FY 2025
Net Margin 98.5%
FY 2016: -391.9%FY 2017: -1855.0%FY 2018: -357.0%FY 2019: -322.1%FY 2020: -386.9%FY 2021: -360.6%FY 2022: 1698.5%FY 2023: -96.1%FY 2024: -87.6%FY 2025: 98.5%
FY 2016 5y median -87.6% FY 2025
ROE 35.7%
FY 2016: -54.4%FY 2017: -247.8%FY 2018: 417.8%FY 2019: 105.6%FY 2020: 91.5%FY 2021: 58.9%FY 2022: 197.4%FY 2023: -25.9%FY 2024: -32.1%FY 2025: 35.7%
FY 2016 5y median 35.7% FY 2025
ROIC -2.4%
FY 2016: -30.6%FY 2017: -68.7%FY 2018: -49.3%FY 2019: -78.3%FY 2020: -77.2%FY 2021: -77.2%FY 2022: -15.7%FY 2023: -15.5%FY 2024: -14.1%FY 2025: -2.4%
FY 2016 5y median -15.5% FY 2025
ROA 21.8%
FY 2016: -29.8%FY 2017: -64.7%FY 2018: -38.5%FY 2019: -57.8%FY 2020: -59.3%FY 2021: -53.2%FY 2022: 143.6%FY 2023: -14.4%FY 2024: -15.9%FY 2025: 21.8%
FY 2016 5y median -14.4% FY 2025

Growth (YoY)

Revenue 66.9%
FY 2016: 15.5%FY 2017: -68.4%FY 2018: 292.4%FY 2019: 21.6%FY 2020: -2.1%FY 2021: -23.0%FY 2022: -7.2%FY 2023: 11.8%FY 2024: 12.1%FY 2025: 66.9%
FY 2016 FY 2025
Operating Income 71.8%
FY 2016: 0.8%FY 2017: -44.1%FY 2018: 8.2%FY 2019: -5.5%FY 2020: -18.1%FY 2021: 13.4%FY 2022: 64.3%FY 2023: 39.1%FY 2024: 16.2%FY 2025: 71.8%
FY 2016 FY 2025
EPS (diluted) 279.1%
FY 2016: 20.2%FY 2017: -27.9%FY 2018: 26.8%FY 2019: -6.5%FY 2020: -4.9%FY 2021: 35.7%FY 2022: 56.1%FY 2023: 20.6%FY 2024: -15.0%FY 2025: 279.1%
FY 2016 FY 2025
Free Cash Flow 2109.8%
FY 2016: 41.0%FY 2017: -101.2%FY 2018: 41.0%FY 2019: -101.0%FY 2020: -6.5%FY 2021: 17.8%FY 2022: 11.2%FY 2023: 84.3%FY 2024: 59.8%FY 2025: 2109.8%
FY 2016 FY 2025

Financial Health

Current Ratio 10.9×
FY 2016: 10.7×FY 2017: 6.1×FY 2018: 5.4×FY 2019: 3.0×FY 2020: 3.2×FY 2021: 4.3×FY 2022: 12.3×FY 2023: 5.4×FY 2024: 5.0×FY 2025: 10.9×
FY 2016 5y median 5.4× FY 2025
Quick Ratio 10.9×
FY 2016: 10.5×FY 2017: 5.8×FY 2018: 5.4×FY 2019: 3.0×FY 2020: 3.2×FY 2021: 4.3×FY 2022: 12.3×FY 2023: 5.4×FY 2024: 5.0×FY 2025: 10.9×
FY 2016 5y median 5.4× FY 2025
Debt / Equity 0.3×
FY 2016: 0.6×FY 2017: 1.9×FY 2018: -8.8×FY 2019: -2.3×FY 2020: -2.2×FY 2021: -2.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.7×
FY 2016: 0.7×FY 2017: -0.5×FY 2018: -0.4×FY 2019: -2.2×FY 2020: -2.1×FY 2021: -2.5×FY 2022: 3.4×FY 2023: -0.2×FY 2024: -0.3×FY 2025: -0.7×
FY 2016 5y median -0.3× FY 2025
Interest Coverage -5.4×
FY 2016: -129×FY 2017: -30.4×FY 2018: -22.8×FY 2019: -7.9×FY 2020: -34.8×FY 2021: -30.2×FY 2022: -14.4×FY 2023: -23.8×FY 2024: -18.4×FY 2025: -5.4×
FY 2016 5y median -18.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31